All set to begin with clinical trials of the Japanese drug Avigan in the Philippines! The Philippines is one of the 43 countries participating in the trial.
Japan covid 19 vaccine news is officially announced by the Philippine government after a shipment of 199, 000 tablets of Avigan sent by Japan as part of a grant-in-aid in Manila.
While the Japanese embassy doubts the effectiveness of the anti-flu drug Avigan in treating COVID-19, many experts are optimistic to get positive results in a fight against the SARS-CoV-2.
Previously, health professionals used drugs such as interferon, favipiravir, ribavirin, and lopinavir for the treatment of severe acute respiratory syndrome and the Middle East respiratory syndrome. However, the effectiveness of these drugs is under doubt, said the project researchers.
Avigian may combat SARS-CoV-2
As per the Japan Homegrown covid 19 vaccine trials update, the Philippines will begin clinical trials on August 14 in Southeast Asia’s worst outbreak that will cover 100 patients with age ranges from 18-74 years.
Maria Rosario Vergeire (Health Undersecretary) said, “The Japan covid-19 vaccine trials for the antiviral drug will be conducted across four hospitals in metropolitan Manila. Some initial preparations and regulatory procedures need to be undertaken before beginning with the clinical trials in the Philippines.
We are waiting for the trials to remain successful and once it is, the drug could be reasonably manufactured locally under license by its Japanese maker, said by Fujifilm Toyama Chemical, Leachon. Since the patent of Avigan’s active ingredient, favipiravir expired last year, local drug companies are on their way to produce a generic version of it.
The disease control center in Taiwan brings out the early embryonic deaths caused by the Avigan. One of the clinical studies conducted in Japan suggested avoiding the use in pregnancy as it can raise blood uric acid levels.
Glenmark Pharmaceuticals, a reputed drug agency in Mumbai already on its way to producing a version of favipiravir under the brand name FabiFlu. Glenmark produces 400 mg pill to meet the market requirement of Covid-19 treatment. This is because the Japan Homegrown COVID-19 vaccine trials require a patient to ingest 18 pills ( of 200 mg each).
In India, GRA and Dr. Reddy’s Laboratories will start selling the antiviral drug Avigan. The authorities made the announcement after the government approved the drug’s active ingredient, FavipiravIr for the treatment of patients infected with COVID-19.
The clinical trials for it are underway in the United States, Japan, China, the Middle East, and other countries. The effectiveness of Avigan has been confirmed in reducing fever and shortening recovery time in the patients specifically in the initial stages of infection with COVID-19.
We will count the regulatory process for Avigan as an important milestone. In the coming future, the company is expecting more approvals focusing to meet the growing demand of the market, said Mitch Wilson (CEO of GRA).
COVID-19 Cure, the optimism grows as researchers are about to begin clinical trials for Japan’s Homegrown virus drug. The Covid 19 vaccine latest update Japan brings great hope for the millions of affected worldwide.
Till now, no proven cure has come up for the virus, but the multipurpose drugs and the continuous efforts by the healthcare professionals have significantly contributed towards reducing the fatality rate.